Suppr超能文献

高产的常规轻链文库产生了多样化的高亲和力双特异性抗体面板。

Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies.

机构信息

a Oncology Research and Development , Pfizer Inc. , South San Francisco , CA , USA.

出版信息

MAbs. 2018 Feb/Mar;10(2):256-268. doi: 10.1080/19420862.2017.1406570. Epub 2017 Dec 14.

Abstract

The commercial success of bispecific antibodies generally has been hindered by the complexities associated with generating appropriate molecules for both research scale and large scale manufacturing purposes. Bispecific IgG (BsIgG) based on two antibodies that use an identical common light chain can be combined with a minimal set of Fc mutations to drive heavy chain heterodimerization in order to address these challenges. However, the facile generation of common light chain antibodies with properties similar to traditional monoclonal antibodies has not been demonstrated and they have only been used sparingly. Here, we describe the design of a synthetic human antibody library based on common light chains to generate antibodies with biochemical and biophysical properties that are indistinguishable to traditional therapeutic monoclonal antibodies. We used this library to generate diverse panels of well-behaved, high affinity antibodies toward a variety of epitopes across multiple antigens, including mouse 4-1BB, a therapeutically important T cell costimulatory receptor. Over 200 BsIgG toward 4-1BB were generated using an automated purification method we developed that enables milligram-scale production of BsIgG. This approach allowed us to identify antibodies with a wide range of agonistic activity that are being used to further investigate the therapeutic potential of antibodies targeting one or more epitopes of 4-1BB.

摘要

双特异性抗体的商业成功通常受到与研究规模和大规模制造相关的复杂性的阻碍。基于使用相同公共轻链的两种抗体的双特异性 IgG(BsIgG)可以与最小数量的 Fc 突变相结合,以驱动重链异二聚化,从而解决这些挑战。然而,具有类似于传统单克隆抗体特性的公共轻链抗体的简便生成尚未得到证明,并且它们仅被少量使用。在这里,我们描述了一种基于公共轻链的合成人抗体文库的设计,以生成具有与传统治疗性单克隆抗体无法区分的生化和生物物理特性的抗体。我们使用该文库生成了针对多种抗原的各种表位的多样化高亲和力抗体,包括治疗上重要的 T 细胞共刺激受体 mouse 4-1BB。我们使用我们开发的自动化纯化方法生成了 200 多种针对 4-1BB 的 BsIgG,该方法能够进行毫克级 BsIgG 的生产。这种方法使我们能够鉴定出具有广泛激动活性的抗体,这些抗体正在被用于进一步研究针对 4-1BB 一个或多个表位的抗体的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eba/5825193/eca1537ffe80/kmab-10-02-1406570-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验